Poor Recovery and Short Survival of Infused Factor X in a Case of Acquired Factor X Deficiency and Amyloidosis

Thromb Haemost 1999; 82(04): 1375-1376
DOI: 10.1055/s-0037-1614403

Letters to the Editor

Schattauer GmbH

E. M. Duncan

¹From the Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, and Adelaide, Australia

,

J. Cole

¹From the Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, and Adelaide, Australia

,

A. R. Clarkson

²Dept of Renal Medicine, Royal Adelaide Hospital, Adelaide, Australia

,

J. V. Lloyd

¹From the Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, and Adelaide, Australia

References
1 Furie B, Voo L, McAdam K, Furie BC. Mechanism of factor X deficiency in systemic amyloidosis. N Engl J Med 1981; 304: 827-30.
2 Greipp PR, Kyle RA, Bowie EJW. Factor X deficiency in amyloidosis: a critical review. Am J Haem 1981; 11: 443-50.
3 Gloy J, Bohler J, Schollmeyer P, Pavenstadt H. Primary amyloidosis with severe nephrotic syndrome and acquired factor X deficiency. Nephrol Dialysis Transplant 1997; 12: 588-90.
4 Bohrer H, Waldherr R, Martin E, Linke RP, Lin J, Ziegler R, Ritz E, Nawroth PP. Splenectomy in an uraemic patient with acquired factor X deficiency due to AL amyloidosis. Nephrol Dialysis Transplant 1998; 13: 190-3.
5 Furie B, Greene E, Furie BC. Syndrome of acquired factor X deficiency and systemic amyloidosis. In vivo studies of the metabolic fate of factor X. N Engl J Med 1977; 297: 81-5.